Mary AG Now Has Room to Grow Hemp in China Through CBDer Partnership

1w
4m read
Summary

Markham, Ontario–(Newsfile Corp. – August 12, 2021) – Mary Agrotechnologies Inc. (CSE: MARY) (“Mary AG” or “the Company”) announces that it has signed a memorandum of understanding (“MOU”) to form an in-depth partnership with CBDer Biotechnology (“CBDer”), headquartered in Yunnan China. The MOU mainly encompasses: Working with CBDer to further develop China’s industrial hemp market. Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor industrial hemp cultivation in China’s only legalized province for cannabinoid extraction. A founding member of the Industrial Hemp branch of China National Narcotic Drugs Association, CBDer is also an R&D partner with KPC Pharmaceuticals (SSE: 600422) in breeding high CBD potency hemp cultivars. Further, any forward-looking information speaks only as of the date on which such statement is made.

Article Preview

Markham, Ontario–(Newsfile Corp. – August 12, 2021) – Mary Agrotechnologies Inc. (CSE: MARY) (“Mary AG” or “the Company”) announces that it has signed a memorandum of understanding (“MOU”) to form an in-depth partnership with CBDer Biotechnology (“CBDer”), headquartered in Yunnan China. This partnership marks Mary AG’s first application of farm-level technology, taking its knowledge in automated systems and applying that expertise to a holistic, controlled growing condition that incorporates automated plant health assessment.

Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor...

Read the full article @ Cannabis Law Report